Indeed, the simultaneous modulation of 5-HT6R and AChE could lead to an interesting synergistic effect in the treatment of AD, as demonstrated with the use of idalopirdine and donepezil in the clinical trials. The gene discussed is ACHE; the disease is Alzheimer disease.